Recent Comments
- Bill on The Declaration of Pandemics
- Margaret McGregor on The Declaration of Pandemics
- admin on A Surgeon’s Story: Decision-making
- Margaret McGregor on A Surgeon’s Story: Decision-making
- LB on Has Bobby Kennedy’s campaign been infiltrated by intelligence operations?
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (17,719)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (15,901)
- New treatment paradigm for C. Diff colitis (14,804)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (14,769)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,226)
- How the FDA regulates compounding pharmacies (14,085)
- The Healthcare Channel hits 10 (13,593)
- The new CDC guidelines for prescribing opioid pain pills (9,085)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (8,600)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (8,305)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: FDA
Federal Court of Appeals Rules that FDA Overstepped by Restricting Ivermectin Use
September 2, 2023- by Steven E. Greer, MD
Posted in - Generics, - Pharma, CDC, Congress, FDA
Leave a comment
Greer v. The Lancet 4:23-cv-03761 S.D.T.X.
October 1, 2023- by Steven E. Greer, MD
Posted in - Opinion, CDC, CMS, Congress, FDA, Infectious disease, NIH, Pulmonology
Leave a comment
The Declaration of Pandemics
Posted in - Opinion, - Policy, CDC, CMS, Congress, FDA, Infectious disease, NIH
2 Comments
Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
The transcript is found here May 19, 2023- by Steven E. Greer, MD
mRNA vaccine boosters and impaired immune system response
February 3, 2024- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, CDC, Congress, FDA, Infectious disease
Leave a comment
Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies
July 12, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology
Leave a comment
Interview with Leslie Manookian, founder of Health Freedom Defense legal fund fighting mask and vaccine mandates
October 6, 2023- by Steven E. Greer, MD
How to properly study autism
Update January 8, 2024-
Posted in - Opinion, - Pharma, - Policy, CDC, FDA, Neurology, Neurosurgery, NIH, Pediatrics, Primary care medicine, Psychology Psychiatry
Leave a comment
Any type of coronavirus vaccine (i.e., gene therapy) that uses the spike-protein will be deadly
February 20, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, FDA
Leave a comment
Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA
January 19, 2024- by Steven E. Greer, MD
Posted in - Opinion, - Pharma, CDC, Congress, FDA, Infectious disease
5 Comments
Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham
July 7, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH
Leave a comment
Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity
September 1, 2023- by Sucharit Bhakdi, MD et al
Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)
Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.
Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease
Leave a comment
Ivermectin works against COVID in double blind, randomized, controlled trial
May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.
Steven E. Greer, MD on OANN discussing virus therapies
April 16, 2020
Did the COVID vaccines change the human genome?
May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology
Leave a comment
Rudy Giuliani interviews Steven E. Greer, MD on WABC radio- May 6, 2020
May 6, 2020
Posted in - Opinion, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, NIH
Leave a comment
Federal appeals court rules that our federal government violated the First Amendment during the pandemic
September 8, 2023- by Steven Greer (pro se litigator extraordinaire)
FDA CDER Director on Benlysta for lupus and adaptive clinical trials.
July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,
Posted in - Biotech, - Pharma, FDA, Rheumatology
Leave a comment